SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
ayeyou
Hodor
To: Hodor who wrote (24536)5/30/2014 9:01:21 PM
From: ogi2 Recommendations  Read Replies (1) of 49402
 
I too am taking a longer term view of TLT, not trying to trade this breakout but would consider adding on a deeper retrace, in at avg 25. Current burn rate not too high, assume much of current activity will result in warrant exercise
and more cash to the til. TLT on record saying they will need another PP before launching first human trials, 2015. now the warrant cash should allow them the flexibility to undertake another PP without undue pricing pressure.

Meanwhile, I think it worth noting that TLT's destruction of cancer cell nucleus is unlike most pharmaceutical approaches to attacking cancer. Therefore I believe a much higher chance the rodent model can be replicated in humans. Lots of successes in mice models across biotech that do not replicate in humans due to complexity of
differences in biochemistry. But in this instance a dead nucleus is a dead nucleus so long odds vastly improved with or without the newly observed memory function revealed yesterday.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News